Prognosis
Pfizer to Supply U.S. With 100 Million More Vaccine Doses
- Deal will double the doses available for immunization push
- Merck, Warp Speed strike pact on experimental Covid treatment
This article is for subscribers only.
Pfizer Inc. and partner BioNTech SE agreed to supply an additional 100 million doses of their Covid-19 vaccine to the U.S., as the country seeks to widen its immunization program and revive its economy.
The agreement brings the total number of doses to be delivered to the U.S. to 200 million, the companies said Wednesday in a statement. The drugmaker expects to deliver all the doses to U.S. vaccine and drug accelerator Operation Warp Speed by July 31.